Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1080 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-04

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

seroPREvalence vis-à-vis SARS-CoV2 and correlation with clinical forms of COVID-19 in patients followed in Pulmonology in the cluster area of the Grand-Est region.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognostic Factors of COVID19

NCT04405726

SARS-CoV-2

UNKNOWN

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)

NCT04448769

Coronavirus Infection Prevalence

COMPLETED NA

Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.

NCT04677283

Symptoms Related to Covid-19

COMPLETED

Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT)

NCT04597736

Covid19 Contact Case

UNKNOWN NA

Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia

NCT04422613

Pneumonia, Viral

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man or woman from 18 years old and without upper age limit
* Patient followed in pulmonology at Strasbourg University Hospital
* Patient presenting at least one of the following pathologies:

1. severe persistent asthma (200 patients)
2. chest cancer that is active or has received treatment within a period of less than one year (300 patients)
3. history of lung transplantation performed before the start of the epidemic (02/29/2020) (300 patients)
4. idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis (70 patients)
5. pulmonary arterial hypertension (PAH) (group 1 of the international classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)
6. Severe COPD in the respiratory failure stage (150 patients)
* Subject affiliated to a social health insurance protection scheme
* Subject able to understand the objectives of the research
* Subject having signed an informed consent

Exclusion Criteria

* Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
* Subject under safeguard of justice
* Subject under guardianship or guardianship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No